Douglas Carr, SVP Finance & Operations at Century Therapeutics, Inc. (IPSC), sold 264 shares at $2.34 ($618) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Seasonal sale ($618) by SVP Finance & Operations — this insider has traded IPSC in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| IPSC | SELL | 2026-06-15 | $4K | — | Filing → |
| IPSC | SELL | 2026-06-09 | $526 | — | Filing → |
| IPSC | SELL | 2026-03-16 | $36K | — | Filing → |